
Okorio Strengthens Workday Practice with Strategic Hires: Lawrie Henry and Hifzur Meerapatel
DALLAS, March 27, 2025 /PRNewswire/ — Okorio, a premier Workday partner specializing in streamlined, scalable enterprise solutions, is excited to announce... Read more.

CoinList Partners with Institute for Financial Integrity to Further Strengthen Compliance Efforts
WASHINGTON, March 27, 2025 /PRNewswire/ — The Institute for Financial Integrity (IFI) today announced that CoinList, the world’s leading token launch... Read more.

Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation
SOUTH SAN FRANCISCO, Calif., March 27, 2025 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has entered into a settlement... Read more.

First Chiikawa Smartphone App Chiikawa Pocket Officially Released Today
TOKYO, March 27, 2025 /PRNewswire/ — The first mobile app by Applibot, Inc. based on the popular manga Chiikawa by illustrator Nagano, Chiikawa Pocket, officially... Read more.

Bright Power Drives Decarbonization: Measuring 20 Years of Impact on the Built Environment
667M Lbs of CO2 reduced from the environment which is equivalent to 71,000 cars off the road NEW YORK, March 27, 2025 /PRNewswire/ — Since its inception 20... Read more.

Project OWASP Promotes GenAI Security Project to Flagship Status
The OWASP Top 10 for LLM and Generative AI has recognized industry need and expanded scope and become an OWASP Flagship Project WILMINGTON, Del., March 27, 2025... Read more.

DNSFilter Helps MSP Drive Stronger Security Outcomes in the Education Space
Long-time DNSFilter customer sees content filtering as foundational to security offering WASHINGTON, March 27, 2025 /PRNewswire/ — DNSFilter announced today... Read more.

Adaptiva Transforms Vulnerability Management with SentinelOne®
New product automatically remediates vulnerabilities discovered by SentinelOne Singularity™Platform to rapidly eliminate endpoint risks at scale KIRKLAND, Wash.,... Read more.

BREAKING: Dermata’s XYNGARI™ Phase 3 Trial Topline Data Meets All Primary Endpoints
– XYNGARI™ achieved its primary endpoints, demonstrating highly statistically significant and clinically meaningful improvement in acne – –... Read more.

NetActuate Expands New York City Data Center with Massive Capacity Upgrades and Improved Redundancy
NEW YORK, March 27, 2025 /PRNewswire/ — NetActuate has completed a major expansion of its New York City Data Center with 3.2tbps of capacity upgrades and enhanced... Read more.